Home › Funds › FAS Wealth Partners, Inc. › CORT
FAS Wealth Partners, Inc. position in CORT
CORCEPT THERAPEUTICS INC · Health Care
FAS Wealth Partners, Inc. reported holding 324,876 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$28.2M, representing 1.52% of its reported portfolio and ranking #14 among its reported holdings. FAS Wealth Partners, Inc. has disclosed CORT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How FAS Wealth Partners, Inc.'s CORT position evolved
FAS Wealth Partners, Inc. first disclosed a stake in CORT in Q3 2023 at 310,764 shares (US$8.5M). The position peaked in Q1 2025 at 300,263 shares, worth US$34.3M. Across 12 filings, FAS Wealth Partners, Inc. increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 324,876 shares valued at US$28.2M — an increase of 2,506 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 310.76K | $8.47M | New |
| Q4 2023 | 310.29K | $10.08M | Hold |
| Q1 2024 | 311.38K | $7.84M | Hold |
| Q2 2024 | 315.77K | $10.26M | Add |
| Q3 2024 | 315.75K | $14.61M | Hold |
| Q4 2024 | 309.21K | $15.58M | Reduce |
| Q1 2025 | 300.26K | $34.30M | Reduce |
| Q2 2025 | 302.43K | $22.20M | Add |
| Q3 2025 | 308.32K | $25.62M | Add |
| Q4 2025 | 310.02K | $10.79M | Add |
| Q1 2026 | 322.37K | $12.99M | Add |
| Q2 2026 | 324.88K | $28.25M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$457.5M), Parallel Advisors, LLC (US$344.5M), TANG CAPITAL MANAGEMENT LLC (US$130.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 5.26M sh · $457.50M · Q2 2026
- Parallel Advisors, LLC 3.96M sh · $344.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $130.43M · Q2 2026
- MPM BioImpact LLC 771.03K sh · $67.04M · Q2 2026
- EMERALD ADVISERS, LLC 748.33K sh · $65.07M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 464.90K sh · $40.42M · Q2 2026
- PERCEPTIVE ADVISORS LLC 398.38K sh · $34.64M · Q2 2026
More on FAS Wealth Partners, Inc.
FAQ
How long has FAS Wealth Partners, Inc. held CORT?
FAS Wealth Partners, Inc. has disclosed CORT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is FAS Wealth Partners, Inc.'s current position in CORT?
As of Q2 2026, FAS Wealth Partners, Inc. holds 324.88K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $28.25M, representing 1.52% of its reported portfolio and ranking #14.
Has FAS Wealth Partners, Inc. been buying or selling CORT?
In the latest 13F filing (Q2 2026), FAS Wealth Partners, Inc. increased its position in CORT. The position peaked in Q1 2025 at 300.26K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.